{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:19:01Z","timestamp":1763770741033,"version":"3.45.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jmoldx.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:49:36Z","timestamp":1758703776000},"page":"1166-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening"],"prefix":"10.1016","volume":"27","author":[{"given":"Sagee","family":"Tal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan A.","family":"Vowels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-6465","authenticated-orcid":false,"given":"Efstathia","family":"Polychronopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2988-4321","authenticated-orcid":false,"given":"Ranjana S.","family":"Nawgiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4022-6667","authenticated-orcid":false,"given":"Ping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes","key":"10.1016\/j.jmoldx.2025.08.006_bib1"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib4","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib5","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3802\/jgo.2012.23.4.282","article-title":"New insights into cervical cancer screening","volume":"23","author":"Boone","year":"2012","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B","article-title":"The role of cervical cytology in the declining morbidity and mortality of cervical cancer","volume":"34","author":"Cramer","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13224-021-01569-9","article-title":"Advances in HPV screening tests for cervical cancer-A review","volume":"72","author":"Lucksom","year":"2022","journal-title":"J Obstet Gynaecol India"},{"issue":"Suppl 1","key":"10.1016\/j.jmoldx.2025.08.006_bib10","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jcv.2015.10.027","article-title":"A review of the clinical performance of the Aptima HPV assay","volume":"76","author":"Haedicke","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/07853899909115976","article-title":"New concepts on the role of human papillomavirus in cell cycle regulation","volume":"31","author":"Syrj\u00e4nen","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib12","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amepre.2023.04.016","article-title":"Racial and ethnic disparities in cervical cancer screening from three U.S. healthcare settings","volume":"65","author":"Spencer","year":"2023","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib15","article-title":"Increased disparities associated with black women and abnormal cervical cancer screening follow-up","volume":"42","author":"Boitano","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.2985","article-title":"Mediation of racial and ethnic inequities in the diagnosis of advanced-stage cervical cancer by insurance status","volume":"6","author":"Holt","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.22.01424","article-title":"Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype","volume":"41","author":"Cohen","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cncr.24843","article-title":"Cervical cancer incidence among 6 Asian ethnic groups in the United States, 1996 through 2004","volume":"116","author":"Wang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.03386-12","article-title":"Development and characterization of the cobas human papillomavirus test","volume":"51","author":"Rao","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2013.05.038","article-title":"The papillomavirus major capsid protein L1","volume":"445","author":"Buck","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib21","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.path.2018.04.002","article-title":"Head and neck cytopathology: human papillomavirus-positive carcinomas, including diagnostic updates, testing modalities, and recommendations","volume":"11","author":"Madrigal","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib25","first-page":"1105","article-title":"Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997-2012","volume":"26","author":"Baldur-Felskov","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cam4.971","article-title":"Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013","volume":"6","author":"van der Horst","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib29","article-title":"Human papillomavirus-negative cervical cancer: a comprehensive review","volume":"10","author":"Xing","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcp\/aqv085","article-title":"The value of Papanicolaou tests in the diagnosis of endometrial carcinoma: a large study cohort from an academic medical center","volume":"145","author":"Serdy","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dc.24609","article-title":"How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience","volume":"49","author":"Mehta","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cyt.13477","article-title":"Diagnostic value of liquid-based cervical cytology test in endometrial carcinoma","volume":"36","author":"He","year":"2025","journal-title":"Cytopathology"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8793","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/PAS.0000000000002122","article-title":"Incidence and clinicopathologic characteristics of human papillomavirus-independent invasive squamous cell carcinomas of the cervix: a morphologic, immunohistochemical, and human papilloma-virologic study of 670 cases","volume":"47","author":"Stolnicu","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2025.08.006_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41379-022-01052-4","article-title":"Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?","volume":"35","author":"Swid","year":"2022","journal-title":"Mod Pathol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157825002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:14:29Z","timestamp":1763770469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157825002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525157825002181"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.08.006","relation":{},"ISSN":["1525-1578"],"issn-type":[{"type":"print","value":"1525-1578"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance Evaluation of the Aptima hrHPV Nucleic Acid Amplification and Papanicolaou Co-Testing in Cervical Cancer Screening","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}